The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy
Abstract
Fibroblast activation protein (FAP) is best known for its heightened expression in tumour stroma. This atypical serine protease has both dipeptidyl peptidase and endopeptidase activities, cleaving substrates at a post‐proline bond. FAP expression is difficult to detect in non‐diseased adult organs, but is greatly upregulated in sites of tissue remodelling, which include liver fibrosis, lung fibrosis, atherosclerosis, arthritis, tumours and embryonic tissues. Due to its restricted expression pattern and dual enzymatic activities, FAP is emerging as a unique therapeutic target. However, methods to exploit and target this protease are advancing more rapidly than knowledge of the fundamental biology of FAP. This review highlights this imbalance, emphasising the need to better define the substrate repertoire and expression patterns of FAP to elucidate its role in biological and pathological processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The extracellular matrix at a glance
Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Kraman, M., Bambrough, P. J., Arnold, J. N., Roberts, E. W., Magiera, L., Jones, J. O., Gopinathan, A., Tuveson, D. A., & Fearon, D. T. (2010) · Science · doi:10.1126/science.1195300 · Cited by 1,134
Garin-Chesa, P., Old, L. J., & Rettig, W. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7235 · Cited by 748
Protease degradomics: A new challenge for proteomics
López-Otín, C., & Overall, C. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm858 · Cited by 664
Park, J. E., Lenter, M. C., Zimmermann, R. N., Garin-Chesa, P., Old, L. J., & Rettig, W. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36505 · Cited by 586
Kleifeld, O., Doucet, A., auf dem Keller, U., Prudova, A., Schilling, O., Kainthan, R. K., Starr, A. E., Foster, L. J., Kizhakkedathu, J. N., & Overall, C. M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1611 · Cited by 545
Self-citationTran, E., Chinnasamy, D., Yu, Z., Morgan, R. A., Lee, C.-C. R., Restifo, N. P., & Rosenberg, S. A. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130110 · Cited by 463
Scott, A. M., Wiseman, G., Welt, S., Adjei, A. A., Lee, F.-T., Hopkins, W., Divgi, C. R., Hanson, L. J., Mitchell, P., Gansen, D. N., et al. (2003) · PubMed · Cited by 438
3-Dimensional imaging of collagen using second harmonic generation
Cox, G., Kable, E., Jones, A., Fraser, I., Manconi, F., & Gorrell, M. D. (2003) · Journal of Structural Biology · doi:10.1016/s1047-8477(02)00576-2 · Cited by 430
Self-citationTargeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
Santos, A. M., Jung, J., Aziz, N., Kissil, J. L., & Puré, E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38988 · Cited by 428
Roberts, E. W., Deonarine, A., Jones, J. O., Denton, A. E., Feig, C., Lyons, S. K., Espeli, M., Kraman, M., McKenna, B., Wells, R. J. B., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122344 · Cited by 414
Hofheinz, R.-D., al-Batran, S.-E., Hartmann, F., Hartung, G., Jäger, D., Renner, C., Tanswell, P., Kunz, U., Amelsberg, A., Kuthan, H., et al. (2003) · Oncology Research and Treatment · doi:10.1159/000069863 · Cited by 374
In search of partners: linking extracellular proteases to substrates
Overall, C. M., & Blobel, C. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2120 · Cited by 349
Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Kakarla, S., Chow, K. K., Mata, M., Shaffer, D. R., Song, X.-T., Wu, M.-F., Liu, H., Wang, L. L., Rowley, D. R., Pfizenmaier, K., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.110 · Cited by 346
Levy, M. T., McCaughan, G. W., Abbott, C. A., Park, J. E., Cunningham, A. M., Müller, E., Rettig, W. J., & Gorrell, M. D. (1999) · Hepatology · doi:10.1002/hep.510290631 · Cited by 336
Self-citationDipeptidyl peptidase IV and related enzymes in cell biology and liver disorders
GORRELL, M. D. (2005) · Clinical Science · doi:10.1042/cs20040302 · Cited by 334
Self-citationBrennen, W. N., Isaacs, J. T., & Denmeade, S. R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0340 · Cited by 289
Aertgeerts, K., Levin, I., Shi, L., Snell, G. P., Jennings, A., Prasad, G. S., Zhang, Y., Kraus, M. L., Salakian, S., Sridhar, V., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500092200 · Cited by 285
Prudova, A., auf dem Keller, U., Butler, G. S., & Overall, C. M. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m000050-mcp201 · Cited by 282
Rettig, W. J., Garin-Chesa, P., Beresford, H. R., Oettgen, H. F., Melamed, M. R., & Old, L. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3110 · Cited by 271
Jansen, K., Heirbaut, L., Cheng, J. D., Joossens, J., Ryabtsova, O., Cos, P., Maes, L., Lambeir, A.-M., De Meester, I., Augustyns, K., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300410d · Cited by 260
The thyroid hormone-induced tail resorption program during Xenopus laevis metamorphosis.
Brown, D. D., Wang, Z., Furlow, J. D., Kanamori, A., Schwartzman, R. A., Remo, B. F., & Pinder, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1924 · Cited by 245
Fibroblast Activation Protein and Its Relationship to Clinical Outcome in Pancreatic Adenocarcinoma
Cohen, S. J., Alpaugh, R. K., Palazzo, I., Meropol, N. J., Rogatko, A., Xu, Z., Hoffman, J. P., Weiner, L. M., & Cheng, J. D. (2008) · Pancreas · doi:10.1097/mpa.0b013e31816618ce · Cited by 243
Design of anticancer prodrugs for reductive activation
Chen, Y., & Hu, L. (2009) · Medicinal Research Reviews · doi:10.1002/med.20137 · Cited by 238
Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes
Bauer, S., Jendro, M. C., Wadle, A., Kleber, S., Stenner, F., Dinser, R., Reich, A., Faccin, E., Gödde, S., Dinges, H., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2080 · Cited by 230
Cheng, J. D., Dunbrack, R. L., Valianou, M., Rogatko, A., Alpaugh, R. K., & Weiner, L. M. (2002) · PubMed · Cited by 217
Wang, X. M., Yu, D. M. T., McCaughan, G. W., & Gorrell, M. D. (2005) · Hepatology · doi:10.1002/hep.20853 · Cited by 193
Self-citationAntiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein
Lee, K. N., Jackson, K. W., Christiansen, V. J., Lee, C. S., Chun, J.-G., & McKee, P. A. (2006) · Blood · doi:10.1182/blood-2005-08-3452 · Cited by 190
Brennen, W. N., Rosen, D. M., Wang, H., Isaacs, J. T., & Denmeade, S. R. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs336 · Cited by 188
The dipeptidyl peptidase IV family in cancer and cell biology
Yu, D. M. T., Yao, T., Chowdhury, S., Nadvi, N. A., Osborne, B., Church, W. B., McCaughan, G. W., & Gorrell, M. D. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07526.x · Cited by 183
Self-citationBrokopp, C. E., Schoenauer, R., Richards, P., Bauer, S., Lohmann, C., Emmert, M. Y., Weber, B., Winnik, S., Aikawa, E., Graves, K., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq519 · Cited by 166
Fibroblast Activation Protein in Remodeling Tissues
Jacob, M., Chang, L., & Pure, E. (2012) · Current Molecular Medicine · doi:10.2174/156652412803833607 · Cited by 164
Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis
Aimes, R., Zijlstra, A., Hooper, J., Ogbourne, S., Sit, M.-L., Fuchs, S., Gotley, D., Quigley, J., & Antalis, T. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613388 · Cited by 163
Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin
LeBeau, A. M., Brennen, W. N., Aggarwal, S., & Denmeade, S. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1170 · Cited by 159
Levy, M. T., McCaughan, G. W., Marinos, G., & Gorrell, M. D. (2002) · Liver International · doi:10.1034/j.1600-0676.2002.01503.x · Cited by 154
Self-citationDoucet, A., Butler, G. S., Rodriáguez, D., Prudova, A., & Overall, C. M. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800012-mcp200 · Cited by 150
Becker‐Pauly, C., Barré, O., Schilling, O., Keller, U. A. D., Ohler, A., Broder, C., Schutte, A. H., Kappelhoff, R., Stöcker, W., & Overall, C. M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.009233 · Cited by 147
Self-citationChristiansen, V. J., Jackson, K. W., Lee, K. N., & McKee, P. A. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.11.006 · Cited by 137
Gao, M., Kim, B. G., Kang, S., Choi, Y. P., Park, H., Kang, K. S., & Cho, N. H. (2010) · Journal of Cell Science · doi:10.1242/jcs.072900 · Cited by 136
Keane, F. M., Yao, T., Seelk, S., Gall, M. G., Chowdhury, S., Poplawski, S. E., Lai, J. H.-S., Li, Y., Wu, W., Farrell, P., et al. (2013) · FEBS Open Bio · doi:10.1016/j.fob.2013.12.001 · Cited by 136
Self-citationKeane, F. M., Nadvi, N. A., Yao, T., & Gorrell, M. D. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08051.x · Cited by 130
Self-citationA novel plasma proteinase potentiates α2-antiplasmin inhibition of fibrin digestion
Lee, K. N., Jackson, K. W., Christiansen, V. J., Chung, K. H., & McKee, P. A. (2004) · Blood · doi:10.1182/blood-2003-12-4240 · Cited by 126
Global kinetic analysis of proteolysis via quantitative targeted proteomics
Agard, N. J., Mahrus, S., Trinidad, J. C., Lynn, A. J., Burlingame, A. L., & Wells, J. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117158109 · Cited by 126
Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
Żukowska, Z., Pons, J., Lee, E. W., & Li, L. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y03-006 · Cited by 125
Kinsinger, C. R., Apffel, J., Baker, M. S., Bian, X., Borchers, C. H., Bradshaw, R. A., Brusniak, M., Chan, D. W., Deutsch, E. W., Domon, B., et al. (2011) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1074/mcp.o111.015446 · Cited by 122
Poplawski, S. E., Lai, J. H.-S., Li, Y., Jin, Z., Liu, Y., Wu, W., Wu, Y. H., Zhou, Y., Sudmeier, J. L., Sanford, D. G., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400351a · Cited by 120
Targeted Disruption of Mouse Fibroblast Activation Protein
Niedermeyer, J., Kriz, M., Hilberg, F., Garin‐Chesa, P., Bamberger, U., Lenter, M., Park, J., Viertel, B., Püschner, H., Mauz, M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1089-1094.2000 · Cited by 119
Edosada, C. Y., Quan, C. L., Wiesmann, C., Tran, T., Sutherlin, D., Reynolds, M., Elliott, J. M., Raab, H. E., Fairbrother, W. J., & Wolf, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511112200 · Cited by 114
Metalloprotease Meprin β Generates Nontoxic N-terminal Amyloid Precursor Protein Fragments in Vivo
Jefferson, T., Čaušević, M., auf dem Keller, U., Schilling, O., Isbert, S., Geyer, R., Maier, W., Tschickardt, S., Jumpertz, T., Weggen, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252718 · Cited by 108
Self-citationEdosada, C. Y., Quan, C. L., Tran, T., Pham, V. C., Wiesmann, C., Fairbrother, W. J., & Wolf, B. B. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.087 · Cited by 106
Aggarwal, S., Brennen, W. N., Kole, T. P., Schneider, E., Topaloglu, Ö., Yates, M. S., Cotter, R. J., & Denmeade, S. R. (2007) · Biochemistry · doi:10.1021/bi701921b · Cited by 96
Milner, J. M., Kevorkian, L., Young, D. A., Jones, D., Wait, R., Donell, S. T., Barksby, E., Patterson, A. M., Middleton, J., Cravatt, B. F., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1877 · Cited by 93
Expression of the fibroblast activation protein during mouse embryo development
Niedermeyer, J., Garin‐Chesa, P., Kriz, M., Hilberg, F., Mueller, E., Bamberger, U., Rettig, W. J., & Schnapp, A. (2001) · The International Journal of Developmental Biology · doi:10.1387/ijdb.11330865 · Cited by 92
Niedermeyer, J., Scanlan, M. J., Garin‐Chesa, P., Daiber, C., Fiebig, H., Old, L. J., Rettig, W. J., & Schnapp, A. (1997) · International Journal of Cancer · Cited by 91
Advances in Understanding the Expression and Function of Dipeptidyl Peptidase 8 and 9
Zhang, H. E., Chen, Y., Keane, F. M., & Gorrell, M. D. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0272 · Cited by 91
Self-citationWilson, C. H., Indarto, D., Doucet, A., Pogson, L. D., Pitman, M. R., McNicholas, K., Menz, R. I., Overall, C. M., & Abbott, C. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445841 · Cited by 69
Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug
Huang, S., Fang, R. M., Xu, J., Qiu, S., Zhang, H., Du, J., & Cai, S. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2010.511225 · Cited by 67
Expanding the Dipeptidyl Peptidase 4-Regulated Peptidome via an Optimized Peptidomics Platform
Tinoco, A. D., Tagore, D. M., & Saghatelian, A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909524e · Cited by 64
Peptidase substrates via global peptide profiling
Tagore, D. M., Nolte, W. M., Neveu, J. M., Rangel, R., Guzman‐Rojas, L., Pasqualini, R., Arap, W., Lane, W. S., & Saghatelian, A. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.126 · Cited by 63
Walsh, M. P., Duncan, B. B., Larabee, S. M., Krauss, A. C., Davis, J. P. E., Cui, Y., Kim, S. Y., Guimond, M., Bachovchin, W. W., & Fry, T. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058860 · Cited by 56
Christiansen, V. J., Jackson, K. W., Lee, K. N., Downs, T., & McKee, P. A. (2013) · Neoplasia · doi:10.1593/neo.121850 · Cited by 54
Goodman, J. D., Rozypal, T. L., & Kelly, T. J. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1025493605850 · Cited by 51
Lee, K. N., Jackson, K. W., Terzyan, S. S., Christiansen, V. J., & McKee, P. A. (2009) · Biochemistry · doi:10.1021/bi900257m · Cited by 33
Tholen, S., Biniossek, M. L., Geßler, A.-L., Müller, S., Weißer, J., Kizhakkedathu, J. N., Reinheckel, T., & Schilling, O. (2011) · Biological Chemistry · doi:10.1515/bc.2011.162 · Cited by 31
Self-citationJambunathan, K., Watson, D. S., Endsley, A. N., Kodukula, K., & Galande, A. K. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.015 · Cited by 22
Fibroblast Activation Protein α
Gorrell, M. D., & Park, J. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382219-2.00750-x · Cited by 12
Self-citation
Cited by
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Kratochwil, C., Flechsig, P., Lindner, T., Abderrahim, L., Altmann, A., Mier, W., Adeberg, S., Rathke, H., Röhrich, M., Winter, H., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.227967 · Cited by 1,464
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
Loktev, A., Lindner, T., Mier, W., Debus, J., Altmann, A., Jäger, D., Giesel, F., Kratochwil, C., Barthe, P., Roumestand, C., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.210435 · Cited by 777
Giesel, F. L., Kratochwil, C., Lindner, T., Marschalek, M. M., Loktev, A., Lehnert, W., Debus, J., Jäger, D., Flechsig, P., Altmann, A., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.215913 · Cited by 740
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
Geng, L., Lam, K. S. L., & Xu, A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0386-0 · Cited by 607
Chen, H., Pang, Y., Wu, J., Zhao, L., Hao, B., Wu, J., Wei, J., Wu, S., Zhao, L., Luo, Z., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04769-z · Cited by 545
Metadata
- Authors
- Hamson, E. J., Keane, F. M., Tholen, S., Schilling, O., & Gorrell, M. D.
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2014-03-24
- Volume
- 8
- Issue
- 5-6
- Pages
- 454-463
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2077759978
- Cited by
- 496
- References
- 66
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.